サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：整形外科用生体材料の世界市場：2023-2030年
市場調査レポート
商品コード
1351007

整形外科用生体材料の世界市場：2023-2030年

Global Orthopedic Biomaterials Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 128 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
整形外科用生体材料の世界市場：2023-2030年
出版日: 2023年08月30日
発行: Orion Market Research
ページ情報: 英文 128 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の整形外科用バイオマテリアル市場は、予測期間中にCAGR 7.2%というかなりのCAGRで成長すると予測されています。市場の成長は、整形外科疾患の有病率の増加、整形外科手術件数の増加、技術の進歩、老人人口の増加などの要因に起因しています。さらに、低侵襲手術の需要、ロボット支援手術の採用、高度な整形外科用生体材料の入手可能性などの要因が、整形外科用生体材料市場の需要を促進すると予想されています。

世界の整形外科バイオマテリアル市場の開拓は、政府機関だけでなく非政府機関も、さまざまな新しい新規バイオマテリアルの開発のために大学への資金や助成金を増やしていることが主な要因です。例えば、2018年3月、ドレクセル大学は全米科学財団に総額20万米ドルを供与しました。この助成金は、バイオマテリアルが介在するマクロファージの挙動制御がバイオマテリアルの血管形成にどのように影響するかに関する研究を推進するために提供されます。さらに、移植可能な機器に対する需要の増加や再生医療に関する研究の増加といった要因が、市場の成長をさらに後押ししています。しかし、厳しい臨床・規制プロセスや不利なヘルスケア改革は、整形外科用バイオマテリアル市場の成長にとって課題となる可能性があります。

セグメント別展望

整形外科用バイオマテリアルの世界市場でセラミックス＆生体活性ガラスセグメントが最も速い成長を示す

材料タイプ別では、セラミックス＆生体活性ガラスセグメントが予測期間中に最も速い成長を示すと予測されています。いくつかの脊椎手術や躯体間固定術の採用が増加していることが、この市場セグメントの成長に寄与しています。また、固定術における合成ケージやペディクル・スクリューの増加が、このセグメントの成長を後押ししています。合成ケージとペディクル・スクリューは、対象となる患者の安定性を維持し、同種移植の癒合率を高める。

地域別展望

世界の整形外科用生体材料市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）など、地域別にさらに細分化されています。なかでもアジア太平洋市場は、予測期間中にかなりの成長を遂げると予測されています。アジア太平洋地域は、高齢者人口の増加と骨折や手術のケースの増加により、整形外科用バイオマテリアル市場でかなりの成長率を示すと予測されています。インドと中国はアジア太平洋の主要経済国であり、バイオマテリアル市場はこれらの地域で大きく成長します。さらに、この地域には様々な研究機関が存在し、投資がアジア太平洋の整形外科用バイオマテリアル市場を押し上げると思われます。さらに、この地域は、ローカル市場だけでなく世界市場での存在感を強化するために戦略的イニシアチブを採用しています。例えば、2019年11月、日本を拠点とする三菱化学は、米国を拠点とするAdvanSource Biomaterialsと、同社の熱可塑性ポリウレタンエラストマー事業を買収する契約を締結しました。この買収により、同社は事業拠点を世界的に拡大し、国際市場で大きなシェアを獲得することが期待されます。

北米地域が整形外科用バイオマテリアルの世界市場で大きなシェアを占める

整形外科用バイオマテリアルの世界市場では、北米が大きなシェアを占めています。北米では米国が大きなシェアを占めています。整形外科手術の症例が増加しているため、バイオマテリアル市場はこの地域で大きく成長します。さらに、米国の確立されたヘルスケア部門と政府の支援も、整形外科バイオマテリアル市場シェアの一助となると思われます。北米と並んで、欧州も同地域のバイオマテリアル市場の成長にとって大きな可能性を秘めています。欧州のバイオマテリアル市場の成長は、医療分野で天然素材や環境に優しい製品を使用する需要が高まっていることに関連しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Invibio Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Koninklijke DSM N.V.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Stryker Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 整形外科用生体材料の世界市場：材料タイプ別
    • ポリマー
    • セラミックスと生体活性ガラス
    • リン酸カルシウムセメント
    • 金属
    • その他
  • 整形外科用バイオマテリアルの用途別世界シェア
    • 整形生物工学
    • 関節置換/再建
    • 関節内補充療法
    • 整形外科インプラント
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • AdvanSource Biomaterials Corp.
  • CAM Bioceramics B.V.
  • DePuy Synthes Inc.
  • DSM Biomedical B.V.
  • Evonik Industries AG
  • Exactech, Inc.
  • Globus Medical Inc.
  • Heraeus Holding
  • Invibio Ltd.
  • Koninklijke DSM N.V.
  • Matexcel
  • Stryker Corp.
  • Zimmer Biomet Holdings, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY MATERIAL TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL POLYMER BASED ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL CERAMICS & BIOACTIVE GLASSES BASED ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CALCIUM PHOSPHATE CEMENT BASED ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL METAL BASED ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL OTHER MATERIAL BASED ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ORTHOPEDIC BIOMATERIALS FOR ORTHOBIOLOGICS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL ORTHOPEDIC BIOMATERIALS FOR JOINT REPLACEMENT/ RECONSTRUCTION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 10. GLOBAL ORTHOPEDIC BIOMATERIALS FOR VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 11. GLOBAL ORTHOPEDIC BIOMATERIALS FOR ORTHOPEDIC IMPLANTS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 12. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY MATERIAL TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 16. EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY MATERIAL TYPE, 2022-2030 ($ MILLION)
  • 18. EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. ASIA- PACIFIC ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. ASIA- PACIFIC ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY MATERIAL TYPE, 2022-2030 ($ MILLION)
  • 21. ASIA- PACIFIC ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD ORTHOPEDIC BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY MATERIAL TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE BY MATERIAL TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL POLYMER BASED ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL POLYPROPELENE BASED ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL CALCIUM PHOSPHATE CEMENT BASED ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL METAL BASED ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL OTHER MATERIAL BASED ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE BY APPLICATION, 2022 VS 2030 ($ MILLION)
  • 8. GLOBAL ORTHOPEDIC BIOMATERIALS FOR ORTHOBIOLOGICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ORTHOPEDIC BIOMATERIALS FOR JOINT REPLACEMENT/ RECONSTRUCTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL ORTHOPEDIC BIOMATERIALS FOR VISCOSUPPLEMENTATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL ORTHOPEDIC BIOMATERIALS FOR ORTHOPEDIC IMPLANTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ORTHOPEDIC BIOMATERIALS OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027608

Title: Global Orthopedic biomaterial Market Size, Share & Trends Analysis Report, By Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Metal, Others), By Application (Orthobiologics, Joint Replacement/Reconstruction, Viscosupplementation, Orthopedic Implants, Others) Forecast Period (2022-2030).

The global orthopedic biomaterial market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. The growth of the market is attributed to factors such as the increasing prevalence of orthopedic conditions, a rise in the number of orthopedic surgeries, advancements in technology, and the growing geriatric population. Further, factors such as the demand for minimally invasive procedures, the adoption of robotic-assisted surgeries, and the availability of advanced orthopedic biomaterial are expected to fuel the demand for orthopedic biomaterial market.

The growth of the global orthopedic biomaterial market is mainly driven by increased funds and grants by government bodies as well as non-government bodies to the universities for the development of various new novel biomaterials. For instance, In March 2018, Drexel University granted a total of $200,000 to the National Science Foundation. This grant is provided for promoting the research on how biomaterial-mediated control over macrophage behavior affects biomaterial vascularization. Additionally, factors such as increasing demand for implantable devices and increasing research on regenerative medicine further give a boost to the growth of the market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms may present as a challenge for the orthopedic biomaterial market growth.

Segmental Outlook

The global orthopedic biomaterial market is segmented based on material type and application. Based on material type, the market is segmented into polymers, ceramics & bioactive glasses, calcium phosphate cements, metal, and others. Based on application, the market is sub-segmented into Orthobiologics, joint replacement/reconstruction, viscosupplementation, orthopedic implants, and others.

Ceramics & Bioactive Glasses Segment to Exhibit Fastest Growth in the Global Orthopedic Biomaterial Market

The ceramics & bioactive glasses segment by material type is projected to exhibit fastest growth during the forecast period. The increasing adoption of several spine surgeries and interbody fusion procedures are contributing to the growth of this market segment. In addition, an increase in synthetic cages and pedicle screws during fixation procedures drives segment growth. Synthetic cages and pedicle screws maintain stability in the target patient pool and increase allograft fusion rates; which is further contributing to the market growth.

Regional Outlook

The global orthopedic biomaterial market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the Asia-Pacific market is anticipated to cater to a considerable growth over the forecast period. Asia-Pacific is anticipated to exhibit a considerable growth rate in the orthopedic biomaterial market due to the increasing geriatric population coupled with the increased cases of fracture and surgery. India and China are the major economies in Asia-Pacific and the market of biomaterial will grow significantly in these regions. Additionally, the presence of various research institutes in the region and investments would boost the orthopedic biomaterial market in the Asia-Pacific. Further, the region is adopting strategic initiatives to reinforce its presence in local as well as global markets. For instance, in November 2019, a Japan-based company, Mitsubishi Chemical signed an agreement with the US-based AdvanSource Biomaterials for acquiring their thermoplastic polyurethane elastomer business. This acquisition is expected to the company to expand its business footprint globally and capture significant share in the international market.

The North America Region held Considerable Share in the Global Orthopedic Biomaterial Market

North America held a considerable share in the global orthopedic biomaterial market. In North America, the US held a major market share. Owing to the increasing cases of orthopedic surgeries, the market of biomaterial will grow significantly in the region. Additionally, the well-established healthcare sector of the US coupled with government support will also aid in the orthopedic biomaterial market shares. Along with North America, Europe also has good potential for the growth of the biomaterial market in the region. The growth of the biomaterial market in Europe is associated with the increasing demand in the medical sector to use mostly natural and environmentally friendly products.

Market Players Outlook

The major companies serving the global orthopedic biomaterial market include among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Synergy Biomedical, LLC, a developer of innovative biomaterial products, launched BIOSPHERE FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy's proprietary BIOSPHERE Technology, BIOSPHERE FLEX SP Extremities is a sheet putty composed of innovative spherical bioactive glass granules combined with a porous collagen/sodium hyaluronate carrier. This product addition adds to the already highly successful Synergy FLEX sheet putty product portfolio. Flex SP Extremities expects to be an integral solution into the Upper and Lower Extremity market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global orthopedic biomaterial market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Invibio Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Koninklijke DSM N.V.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Stryker Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Orthopedic Biomaterials Market by Material Type
    • 4.1.1. Polymers
    • 4.1.2. Ceramics & Bioactive Glasses
    • 4.1.3. Calcium Phosphate Cement
    • 4.1.4. Metal
    • 4.1.5. Others
  • 4.2. Global Orthopedic Biomaterials Markey by Application
    • 4.2.1. Orthobiologics
    • 4.2.2. Joint Replacement/ Reconstruction
    • 4.2.3. Viscosupplementation
    • 4.2.4. Orthopedic Implants
    • 4.2.5. Other

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AdvanSource Biomaterials Corp.
  • 6.2. CAM Bioceramics B.V.
  • 6.3. DePuy Synthes Inc.
  • 6.4. DSM Biomedical B.V.
  • 6.5. Evonik Industries AG
  • 6.6. Exactech, Inc.
  • 6.7. Globus Medical Inc.
  • 6.8. Heraeus Holding
  • 6.9. Invibio Ltd.
  • 6.10. Koninklijke DSM N.V.
  • 6.11. Matexcel
  • 6.12. Stryker Corp.
  • 6.13. Zimmer Biomet Holdings, Inc.